top of page

Xingui Liu, PhD
Xingui Liu is an Assistant professor at the Department of Medicinal Chemistry, University of Florida. Before starting her independent career, Xingui was a Marie Skłodowska-Curie fellow and Ono rising start fellow at the Center for Targeted Protein Degradation (CeTPD), University of Dundee where she developed PROTAC degraders of Leucine Rich Repeat Kinase 2 (LRRK2), a promising target for Parkinson’s disease. Prior to this, Xingui was a Postdoc associate at the University of Florida. Xingui Liu earned her PhD in Pharmaceutical Science from the University of Arkansas for Medical Sciences in 2018.
bottom of page